Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Veritone, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
8.91
14.4
27
49.6
57.7
115
150
100
92.6
92.2
Cost of revenue
1.58
1.07
6.48
15.3
15.7
22.1
27.4
28.3
27.3
29.6
Gross profit
7.33
13.3
20.6
32.4
42
93.2
122
71.7
65.4
62.6
Research and development
7.9
14
22.1
22.8
14.4
25.1
43.6
40.6
26.8
20.7
Selling and marketing
8.28
14.7
22.5
23.5
19.9
28.9
51.3
44.5
39.8
42.7
General and administrative
14.9
31.4
38
47.3
50.1
91.7
44.2
61.5
58.4
53.3
Operating expenses
31.1
60.1
82.6
96.4
Operating income
-23.8
-46.8
-62
-64.1
-47.7
-61.4
-38
-99.6
-88.2
-81.3
Interest expense
3.89
4.24
Other non-operating income
-3.19
-12.8
0.91
0.54
-0.13
-0.6
-4.35
3.28
0.08
-7.49
Pre-tax income
-27
-59.6
-61.1
-63.5
-47.8
-62
-23.2
-69
-100
-112
Income tax
0.01
0.01
0.02
-1.45
0.08
2.7
2.31
-3.32
-3.86
-0.23
Income from continuing operations
-65.7
-96.3
-112
Net income
-27
-59.6
-61.1
-62.1
-47.9
-64.7
-25.6
-58.6
-37.4
-112
EBITDA
-23.6
-46.5
-58.3
-58.1
-41.3
-52
-15.5
-74.4
-59.7
-54.1
EPS, basic
-13.35
-5.67
-3.18
-2.61
-1.58
-1.94
-0.71
-1.59
-0.98
-1.76
EPS, diluted
-13.35
-5.67
-3.18
-2.61
-1.58
-1.94
-0.71
-1.59
-0.98
-1.76
Shares, basic (weighted)
2.41
11.5
19.3
23.9
30.2
33.3
36
36.9
38
63.3
Shares, diluted (weighted)
2.26
11.3
19.2
23.8
30.2
33.3
36
36.9
38
63.3
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
12.1
29.5
37.5
44.1
115
255
184
46.6
16.9
27.4
Short-term investments
39.6
13.6
Receivables
4.83
7.69
29.1
21.4
16.7
85.1
56
33.9
32
36.8
Other current assets
1.07
2.81
3.58
5.41
6.72
12.1
8.15
0.69
0.76
1.16
Total current assets
21.4
83.8
86.5
81.1
157
379
278
186
59.4
73.9
Property, plant and equipment
0.07
0.68
4.01
3.21
2.35
1.56
5.29
8.08
10.1
9.58
Lease right-of-use assets
1.67
0.84
1.8
Goodwill
0.14
5.51
6.9
6.9
42
46.5
53.5
53.1
54.3
Intangible assets
3.15
20.5
16.1
10.7
93.9
79.7
83.4
59.5
38.6
Other non-current assets
0.91
0.78
1.24
0.32
0.23
0.95
14.4
9.16
15.6
5.6
Total assets
22.3
88.6
118
109
178
518
425
379
198
182
Accounts payable
12.3
13.3
28.7
17
15.6
46.7
36.7
16.6
11
16.5
Accrued liabilities
6.78
6
7.42
2.49
Deferred revenue
9.64
9.08
6.5
10.6
16.4
0.02
12.1
12.3
Total current liabilities
44.5
27.3
56.1
59.7
88.2
191
193
192
61
104
Lease liabilities
1.51
0.31
0.15
1.29
Other non-current liabilities
0.02
1.39
1.38
1.2
13.9
13.8
13.6
11.3
10.4
Total liabilities
44.5
27.3
57.5
61.1
89.4
432
345
341
185
114
Total debt
77.5
41.2
Paid-in capital
171
231
280
368
432
451
468
480
646
Retained earnings
-45.2
-109
-170
-232
-280
-345
-371
-430
-467
-579
Other comprehensive income
-0.14
0
0.05
0.07
-0.1
-0.08
-0.01
0.21
1.08
Shareholders' equity
-45.5
61.3
60.3
47.4
88.2
86.5
79.9
38.1
13.5
68.1
Total equity
-45.5
61.3
60.3
47.4
88.2
86.5
79.9
38.1
13.5
68.1
Total liabilities and equity
22.3
88.6
118
109
178
518
425
379
198
182
Shares outstanding
2.86
17.7
21.1
28.1
34.7
35
36.3
37.2
40.2
92.6
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-27
-59.6
-61.1
-62.1
-47.9
-64.7
-25.6
-58.6
-37.4
-112
Depreciation and amortization
0.15
0.25
3.7
5.95
6.41
9.41
22.5
25.2
28.5
27.2
Stock-based compensation
1.73
16.1
15.5
20.7
19.5
40.1
19.1
10.8
8.13
6.69
Deferred income tax
-6.62
0
0
-1.49
-0.64
-1.56
-4.98
-4.76
-1.33
Change in receivables
1.26
-2.96
-15.5
7.74
4.39
-47.2
29.7
12.4
0.95
-5.69
Change in payables
-9.19
1.02
13.1
-11.7
-1.38
17.9
-10
0.79
-5.46
5.36
Cash from operations
-26.8
-31.9
-41.8
-30.4
1.43
7.23
3.74
-76.4
-24.7
-53.2
Capital expenditures
-0.04
-0.66
-3.72
-0.29
-0.18
-1.02
-4.77
-4.73
-6.1
-4.98
Acquisitions
-5.78
-0.88
-52.8
-4.59
-50.3
Purchases of investments
-39.9
Sales and maturities of investments
26
13.6
Cash from investing
-0.14
-44.3
15.9
12
-0.12
-53.8
-12.1
-54.9
-1.61
-4.98
Debt repaid
-0.38
Stock issued
0.08
56.5
32.8
23.9
66.3
4.5
Cash from financing
19.8
93.7
34.3
24.6
69.4
187
-61.9
26.3
-37.1
69.4
Exchange rate effect
0.41
-0.84
Net change in cash
-7.12
17.5
8.45
6.14
70.8
140
-70.3
-105
-63
10.4
Free cash flow
-26.8
-32.6
-45.5
-30.7
1.26
6.22
-1.03
-81.1
-30.8
-58.2
Interest paid
3.5
2.63
11.4
6.3
Income taxes paid
0.01
0.01
0.01
0.01
0.07
0.13
1.87
2.65
0.56
2.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.31 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
66.2%
Gross profit / revenue.
Operating margin
-90.2%
Operating income / revenue.
EBITDA margin
-63.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-119.4%
Pre-tax income / revenue.
Net margin
-117.5%
Net income / revenue.
FCF margin
-60.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-55.0%
Cash from operations / revenue.
Return on equity (ROE)
-282.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-72.1%
Net income / average total assets.
Return on invested capital (ROIC)
-255.1%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
24.4%
Research and development expense / revenue.
Stock-based pay / revenue
6.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
5.2%
Capital expenditures / revenue.
D&A / revenue
27.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-0.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-14.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
9.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-4.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-20.0%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
8.3%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
406.4%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-5.2%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-5.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-8.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-24.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
0.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
66.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
20.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
16.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.47x
Current assets / current liabilities.
Quick ratio
0.40x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.12x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.97
Revenue / diluted weighted shares.
FCF per share
-$0.58
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.53
Cash from operations / diluted weighted shares.
Book value per share
$0.38
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.45x
Market cap / revenue.
P/B
3.48x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
1.31x
Enterprise value / revenue.
FCF yield
-41.6%
Free cash flow / market cap.
Earnings yield
-81.3%
Net income / market cap (the inverse of P/E).
What was Veritone, Inc.'s revenue in fiscal 2025?
Veritone, Inc. reported revenue of $92.2M for fiscal 2025, 0.5% lower than the year before.
Was Veritone, Inc. profitable in fiscal 2025?
No. It reported a net loss of $111.7M.
How much free cash flow did Veritone, Inc. generate in fiscal 2025?
Cash from operations of $53.2M minus capital expenditures of $5.0M left free cash flow of -$58.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.